✦ LIBER ✦

Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer

✍ Scribed by Rollin, J; Iochmann, S; Bléchet, C; Hubé, F; Régina, S; Guyétant, S; Lemarié, E; Reverdiau, P; Gruel, Y

Book ID: 127301032
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 316 KB
Volume: 92
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602298

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor express

Epidermal growth factor receptor expression, signal pathway, and inhibitors in non–small cell lung cancer

✍ Paul A. Bunn Jr; Wilbur Franklin 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Expression of Angiopoietin-2 gene in non

Expression of Angiopoietin-2 gene in non-small cell lung cancer

✍ Xing Lihua; Zhang Zhenxiang; Xu Yongjian 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 Chinese ⚖ 346 KB

Methylation ofTMEFF2gene in tissue and s

Methylation ofTMEFF2gene in tissue and serum DNA from patients with non-small cell lung cancer

✍ Su Man Lee, Jae Yong Park, Dong Sun Kim 📂 Article 📅 2012 🏛 Korean Society for Molecular and Cellular Biology 🌐 English ⚖ 410 KB

Expression of hENTl and ERCC1 genes in t

Expression of hENTl and ERCC1 genes in tumor tissues non-small cell lung cancer

✍ Wu, Jia–Jia; Jiao, Shun–Chang 📂 Article 📅 2013 🏛 Medknow Publications 🌐 English ⚖ 266 KB

Expression of tissue factor in non-small

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis

✍ Sawada, M; Miyake, S; Ohdama, S; Matsubara, O; Masuda, S; Yakumaru, K; Yoshizawa 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 597 KB

Herceptest: Her2 expression and gene amp

Herceptest: Her2 expression and gene amplification in non-small cell lung cancer

✍ G. Cox; M. Vyberg; B. Melgaard; J. Askaa; A. Oster; K.J. O'Byrne 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 343 KB 👁 2 views

HER2 is an erbB/HER type 1 tyrosine kinase receptor that is frequently over-expressed in malignant epithelial tumours. Herceptin, a humanised mouse monoclonal antibody to HER2, is proven therapeutically in the management of metastatic breast cancer, significantly prolonging survival when combined wi